Annual CFF
$2.33 M
-$1.54 M-39.82%
December 31, 2023
Summary
- As of March 10, 2025, NURO annual cash flow from financing activities is $2.33 million, with the most recent change of -$1.54 million (-39.82%) on December 31, 2023.
- During the last 3 years, NURO annual CFF has fallen by -$1.84 million (-44.19%).
- NURO annual CFF is now -92.66% below its all-time high of $31.67 million, reached on December 31, 2004.
Performance
NURO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$2600.00-100.00%
September 30, 2024
Summary
- As of March 10, 2025, NURO quarterly cash flow from financing activities is $0.00, with the most recent change of -$2600.00 (-100.00%) on September 30, 2024.
- Over the past year, NURO quarterly CFF has stayed the same.
- NURO quarterly CFF is now -100.00% below its all-time high of $21.34 million, reached on September 30, 2004.
Performance
NURO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.10 M
-$1400.00-0.05%
September 30, 2024
Summary
- As of March 10, 2025, NURO TTM cash flow from financing activities is $3.10 million, with the most recent change of -$1400.00 (-0.05%) on September 30, 2024.
- Over the past year, NURO TTM CFF has stayed the same.
- NURO TTM CFF is now -90.22% below its all-time high of $31.67 million, reached on December 31, 2004.
Performance
NURO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NURO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.8% | 0.0% | 0.0% |
| 3 y3 years | -44.2% | -100.0% | -84.3% |
| 5 y5 years | +10000.0% | -100.0% | -25.7% |
NURO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.1% | at low | -100.0% | +100.0% | -85.6% | +69.4% |
| 5 y | 5-year | -88.1% | >+9999.0% | -100.0% | +100.0% | -85.6% | >+9999.0% |
| alltime | all time | -92.7% | >+9999.0% | -100.0% | +100.0% | -90.2% | +4224.6% |
NeuroMetrix Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $3.10 M(-0.0%) |
| Jun 2024 | - | $2600.00(-99.8%) | $3.10 M(-18.4%) |
| Mar 2024 | - | $1.47 M(-9.4%) | $3.80 M(+63.3%) |
| Dec 2023 | $2.33 M(-39.8%) | $1.62 M(>+9900.0%) | $2.33 M(-11.1%) |
| Sep 2023 | - | $1400.00(-99.8%) | $2.61 M(+0.1%) |
| Jun 2023 | - | $700.10 K(>+9900.0%) | $2.61 M(+36.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $1.92 M(-50.3%) |
| Dec 2022 | $3.86 M(-80.2%) | $1.91 M(>+9900.0%) | $3.86 M(+111.3%) |
| Sep 2022 | - | $0.00(-100.0%) | $1.83 M(-89.7%) |
| Jun 2022 | - | $7800.00(-99.6%) | $17.71 M(-17.7%) |
| Mar 2022 | - | $1.94 M(-1688.8%) | $21.52 M(+10.1%) |
| Dec 2021 | $19.55 M(+369.2%) | -$122.30 K(-100.8%) | $19.55 M(-0.7%) |
| Sep 2021 | - | $15.88 M(+316.3%) | $19.69 M(+417.4%) |
| Jun 2021 | - | $3.82 M(<-9900.0%) | $3.81 M(+3.2%) |
| Mar 2021 | - | -$25.80 K(-263.3%) | $3.69 M(-11.5%) |
| Dec 2020 | $4.17 M(>+9900.0%) | $15.80 K(>+9900.0%) | $4.17 M(+0.2%) |
| Sep 2020 | - | $0.00(-100.0%) | $4.16 M(0.0%) |
| Jun 2020 | - | $3.70 M(+715.3%) | $4.16 M(+787.5%) |
| Mar 2020 | - | $453.50 K(+5867.1%) | $468.60 K(+3003.3%) |
| Dec 2019 | $15.10 K(-18.8%) | $7600.00(>+9900.0%) | $15.10 K(-10.7%) |
| Sep 2019 | - | $0.00(-100.0%) | $16.90 K(-35.5%) |
| Jun 2019 | - | $7500.00(>+9900.0%) | $26.20 K(+40.1%) |
| Mar 2019 | - | $0.00(-100.0%) | $18.70 K(0.0%) |
| Dec 2018 | $18.60 K(-99.9%) | $9400.00(+1.1%) | $18.70 K(-99.4%) |
| Sep 2018 | - | $9300.00(>+9900.0%) | $3.35 M(-49.2%) |
| Jun 2018 | - | $0.00(-100.0%) | $6.60 M(-48.9%) |
| Dec 2017 | $12.91 M(+93.6%) | $3.34 M(+2.5%) | $12.91 M(+34.7%) |
| Sep 2017 | - | $3.26 M(>+9900.0%) | $9.59 M(+53.1%) |
| Jun 2017 | - | $10.40 K(-99.8%) | $6.26 M(-52.0%) |
| Mar 2017 | - | $6.30 M(>+9900.0%) | $13.05 M(+95.7%) |
| Dec 2016 | $6.67 M(-60.6%) | $16.70 K(-124.2%) | $6.67 M(-50.5%) |
| Sep 2016 | - | -$69.00 K(-101.0%) | $13.48 M(-0.5%) |
| Jun 2016 | - | $6.80 M(-8960.5%) | $13.54 M(-19.7%) |
| Mar 2016 | - | -$76.70 K(-101.1%) | $16.86 M(-0.5%) |
| Dec 2015 | $16.94 M(+113.5%) | $6.83 M(>+9900.0%) | $16.94 M(+67.3%) |
| Sep 2015 | - | $0.00(-100.0%) | $10.12 M(+0.4%) |
| Jun 2015 | - | $10.11 M(>+9900.0%) | $10.08 M(+27.1%) |
| Dec 2014 | $7.93 M(+11.1%) | $13.90 K(-133.0%) | $7.93 M(-24.9%) |
| Sep 2014 | - | -$42.10 K(-100.5%) | $10.56 M(+0.3%) |
| Jun 2014 | - | $7.96 M(+201.3%) | $10.53 M(+47.6%) |
| Dec 2013 | $7.14 M | $2.64 M(-3816.3%) | $7.14 M(+58.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$71.10 K(-101.6%) | $4.50 M(-1.4%) |
| Jun 2013 | - | $4.57 M(<-9900.0%) | $4.57 M(-6181.6%) |
| Mar 2013 | - | -$5300.00(-184.1%) | -$75.10 K(-101.0%) |
| Dec 2012 | $7.46 M(>+9900.0%) | $6300.00(-223.5%) | $7.46 M(-0.1%) |
| Sep 2012 | - | -$5100.00(-92.8%) | $7.47 M(-0.0%) |
| Jun 2012 | - | -$71.00 K(-100.9%) | $7.47 M(-1.1%) |
| Mar 2012 | - | $7.53 M(>+9900.0%) | $7.55 M(>+9900.0%) |
| Dec 2011 | $14.50 K(-91.4%) | $13.20 K(-512.5%) | $14.60 K(-56.2%) |
| Sep 2011 | - | -$3200.00(-129.6%) | $33.30 K(+16.0%) |
| Jun 2011 | - | $10.80 K(-274.2%) | $28.70 K(+170.8%) |
| Mar 2011 | - | -$6200.00(-119.4%) | $10.60 K(-93.7%) |
| Dec 2010 | $168.00 K(-99.0%) | $31.90 K(-509.0%) | $168.00 K(+95.1%) |
| Sep 2010 | - | -$7800.00(+6.8%) | $86.10 K(-99.5%) |
| Jun 2010 | - | -$7300.00(-104.8%) | $17.37 M(-0.6%) |
| Mar 2010 | - | $151.20 K(-402.4%) | $17.47 M(+0.0%) |
| Dec 2009 | $17.46 M(>+9900.0%) | -$50.00 K(-100.3%) | $17.46 M(-0.6%) |
| Sep 2009 | - | $17.28 M(>+9900.0%) | $17.57 M(+6087.6%) |
| Jun 2009 | - | $89.60 K(-38.2%) | $283.90 K(-2.5%) |
| Mar 2009 | - | $145.10 K(+176.9%) | $291.20 K(+103.8%) |
| Dec 2008 | $142.90 K(-48.7%) | $52.40 K(-1737.5%) | $142.90 K(-30.7%) |
| Sep 2008 | - | -$3200.00(-103.3%) | $206.10 K(+0.4%) |
| Jun 2008 | - | $96.90 K(-3128.1%) | $205.20 K(-20.1%) |
| Mar 2008 | - | -$3200.00(-102.8%) | $256.70 K(-7.8%) |
| Dec 2007 | $278.30 K(-82.3%) | $115.60 K(-2919.5%) | $278.30 K(-27.5%) |
| Sep 2007 | - | -$4100.00(-102.8%) | $384.00 K(-44.9%) |
| Jun 2007 | - | $148.40 K(+706.5%) | $696.80 K(-33.2%) |
| Mar 2007 | - | $18.40 K(-91.7%) | $1.04 M(-33.8%) |
| Dec 2006 | $1.58 M(+94.0%) | $221.30 K(-28.3%) | $1.58 M(-15.6%) |
| Sep 2006 | - | $308.70 K(-37.5%) | $1.87 M(+12.7%) |
| Jun 2006 | - | $494.20 K(-10.3%) | $1.66 M(+24.3%) |
| Mar 2006 | - | $551.10 K(+7.3%) | $1.33 M(+64.1%) |
| Dec 2005 | $812.20 K(-97.4%) | $513.50 K(+423.4%) | $812.10 K(+137.0%) |
| Sep 2005 | - | $98.10 K(-42.4%) | $342.60 K(-98.4%) |
| Jun 2005 | - | $170.30 K(+463.9%) | $21.58 M(+1.8%) |
| Mar 2005 | - | $30.20 K(-31.4%) | $21.19 M(-33.1%) |
| Dec 2004 | $31.67 M(+956.1%) | $44.00 K(-99.8%) | $31.67 M(+0.1%) |
| Sep 2004 | - | $21.34 M(-9754.5%) | $31.63 M(+207.3%) |
| Jun 2004 | - | -$221.00 K(-102.1%) | $10.29 M(-2.1%) |
| Mar 2004 | - | $10.51 M | $10.51 M |
| Dec 2003 | $3.00 M(+58.2%) | - | - |
| Dec 2002 | $1.90 M | - | - |
FAQ
- What is NeuroMetrix annual cash flow from financing activities?
- What is the all time high annual CFF for NeuroMetrix?
- What is NeuroMetrix annual CFF year-on-year change?
- What is NeuroMetrix quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NeuroMetrix?
- What is NeuroMetrix quarterly CFF year-on-year change?
- What is NeuroMetrix TTM cash flow from financing activities?
- What is the all time high TTM CFF for NeuroMetrix?
- What is NeuroMetrix TTM CFF year-on-year change?
What is NeuroMetrix annual cash flow from financing activities?
The current annual CFF of NURO is $2.33 M
What is the all time high annual CFF for NeuroMetrix?
NeuroMetrix all-time high annual cash flow from financing activities is $31.67 M
What is NeuroMetrix annual CFF year-on-year change?
Over the past year, NURO annual cash flow from financing activities has changed by -$1.54 M (-39.82%)
What is NeuroMetrix quarterly cash flow from financing activities?
The current quarterly CFF of NURO is $0.00
What is the all time high quarterly CFF for NeuroMetrix?
NeuroMetrix all-time high quarterly cash flow from financing activities is $21.34 M
What is NeuroMetrix quarterly CFF year-on-year change?
Over the past year, NURO quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is NeuroMetrix TTM cash flow from financing activities?
The current TTM CFF of NURO is $3.10 M
What is the all time high TTM CFF for NeuroMetrix?
NeuroMetrix all-time high TTM cash flow from financing activities is $31.67 M
What is NeuroMetrix TTM CFF year-on-year change?
Over the past year, NURO TTM cash flow from financing activities has changed by $0.00 (0.00%)